Preconception Prediabetes Ups Risk for Poor Pregnancy Outcomes in Young Women: New Data
September 25, 2024

The risk of gestational diabetes was 2-fold greater among young women with prediabetes before conceiving compared with those who had normoglycemia.

Strong Link Between Increasing Lp(a) Level and Recurrent ASCVD Events Makes Screening Essential, Investigator Warns
September 25, 2024

A continuous increase in ASCVD risk was seen with higher levels of lipoprotein(a) in the largest study to date of the relationship.

Over Half of US Adults with Uncontrolled HTN Unaware of Their Condition: Daily Dose
September 25, 2024

Your daily dose of the clinical news you may have missed.

Resistant & Refractory Hypertension: 9 Questions for Primary Care
September 24, 2024

How are you managing your patients with resistant or refractory hypertension? How do your strategies align with current guidelines? Try these 9 questions and find out.

Elinzanetant for Menopausal VMS: OASIS Lead Investigator Discusses Results, Side Effects, Next Steps
September 24, 2024

JoAnn Pinkerton, MD, details the positive findings from the OASIS 1, 2, and 3 studies of elinzanetant and highlights next steps in research.

FDA Accepts NDA for Delgocitinib Cream, Developed Specifically to Treat Chronic Hand Eczema
September 24, 2024

Delgocitinib specifically inhibits activation of JAK-STAT signaling in chronic hand eczema and would be an option for people unable to use topical corticosteroids.

FDA Approves Lebrikizumab-lbkz for Moderate to Severe AD: Daily Dose
September 24, 2024

Your daily dose of the clinical news you may have missed.

High Percentage of Patients Seek Mental Health Care from PCPs, According to New Large Analysis
September 23, 2024

One in 9 primary care encounters involved a mental health condition, according to an analysis of over 350 million primary care visits.

COVID-19 Vaccines 2024-2025: Is America Ready and Willing?
September 23, 2024

COVID-19 vaccine myths of many types remain potent enough to raise public health experts' concerns about Americans' willingness to roll up sleeves this year.

Real-World Study Supports Use of DermaSensor in Primary Care to Differentiate Cancerous and Benign Lesions
September 23, 2024

The AI-based point-of-care device outperformed clinician standard of care for sensitivity (90% vs 40%) and had a negative predictive value of 98.9%